Aptinyx to Report Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
businesswire.com
news
2022-10-18 00:00:00

October 18, 2022 07:45 AM Eastern Daylight Time EVANSTON, Ill.--(BUSINESS WIRE)--Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that the company will host a conference call and live webcast on Tuesday, November 8, 2022 at 5:00 p.m. ET to report third quarter 2022 financial results and discuss recent business highlights.

To access the live conference call, please dial 844-200-6205 (domestic) or 929-526-1599 (international) and refer to conference ID 141144.
